Catherine Zeta-Jones lawsuit
This article was originally published in The Rose Sheet
Executive SummaryCompaint filed on behalf of actress in Los Angeles federal court against French skin care marketer Caudalie, Neiman Marcus Group and Turnberry Associates claims companies used her name and persona to promote Caudalie products and services without authorization. Zeta-Jones alleges Caudalie and Neiman Marcus featured her name on promotional materials for Caudalie brand products and spas, complaint states. In addition, the Caudalie anti-aging/Vinotherapie Spa at Turnberry Place in Las Vegas unfairly ties its name and services to Zeta-Jones in promotional materials. Zeta-Jones has never used any of the skin care or other products or services provided by Caudalie, according to court document. Actress seeks general and special damages of no less than $5 mil., in addition to punitive and exemplary damages, permanent injunctive relief and expenses...
You may also be interested in...
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.
As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.